Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03412734 · ClinicalTrials.gov registry record · Phase 4
Vaginal Preparation Prior to Hysterectomy
A Phase 4 study, sponsored by TriHealth.
- Terminated
- Registry status
- Phase 4
- Development phase
- 94
- Enrollment target
NCT03412734 is a Phase 4 study that was terminated before completion, run by TriHealth. The registered enrollment target is 94 participants.
The verdict
NCT03412734, a Phase 4 study, was terminated before completion, sponsored by TriHealth.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 94 participants
- Enrollment target
Study Summary
This is a randomized controlled trial to determine the influence of chlorhexidine gluconate surgical/topical antiseptic solutions on the bacterial environment of the vagina during hysterectomy and compare that to the effect of standard iodine-based preparations on the same.
Interventions
- DRUG Chlorhexidine
- DRUG Iodine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2018-05-18 |
| Est. Completion | 2020-01-29 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03412734
The ClinicalTrials.gov registry entry for NCT03412734 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TriHealth, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Chlorhexidine is the first listed.
NCT03412734 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03412734 about?
NCT03412734 is a clinical study titled "Vaginal Preparation Prior to Hysterectomy". This is a randomized controlled trial to determine the influence of chlorhexidine gluconate surgical/topical antiseptic solutions on the bacterial environment of the vagina during hysterectomy and compare that to the effect of standard iodine-based preparations on the same.
What is the current status of trial NCT03412734?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 94 participants. The study started on 2018-05-18. Estimated completion is 2020-01-29.
What interventions are being tested in trial NCT03412734?
The interventions under investigation include: Chlorhexidine (DRUG), Iodine (DRUG).
Who is sponsoring clinical trial NCT03412734?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.